Literature DB >> 23770691

A largely random AAV integration profile after LPLD gene therapy.

Christine Kaeppel1, Stuart G Beattie, Raffaele Fronza, Richard van Logtenstein, Florence Salmon, Sabine Schmidt, Stephan Wolf, Ali Nowrouzi, Hanno Glimm, Christof von Kalle, Harald Petry, Daniel Gaudet, Manfred Schmidt.   

Abstract

The clinical application of adeno-associated virus vectors (AAVs) is limited because of concerns about AAV integration-mediated tumorigenicity. We performed integration-site analysis after AAV1-LPL(S447X) intramuscular injection in five lipoprotein lipase-deficient subjects, revealing random nuclear integration and hotspots in mitochondria. We conclude that AAV integration is potentially safe and that vector breakage and integration may occur from each position of the vector genome. Future viral integration-site analyses should include the mitochondrial genome.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23770691     DOI: 10.1038/nm.3230

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  25 in total

1.  A greedy algorithm for aligning DNA sequences.

Authors:  Z Zhang; S Schwartz; L Wagner; W Miller
Journal:  J Comput Biol       Date:  2000 Feb-Apr       Impact factor: 1.479

2.  Integration frequency and intermolecular recombination of rAAV vectors in non-human primate skeletal muscle and liver.

Authors:  Ali Nowrouzi; Magalie Penaud-Budloo; Christine Kaeppel; Uwe Appelt; Caroline Le Guiner; Philippe Moullier; Christof von Kalle; Richard O Snyder; Manfred Schmidt
Journal:  Mol Ther       Date:  2012-03-27       Impact factor: 11.454

3.  Redefining the common insertion site.

Authors:  Xiaolin Wu; Brian T Luke; Shawn M Burgess
Journal:  Virology       Date:  2005-11-04       Impact factor: 3.616

4.  Patterns of scAAV vector insertion associated with oncogenic events in a mouse model for genotoxicity.

Authors:  Lucia E Rosas; Jessica L Grieves; Kimberly Zaraspe; Krista Md La Perle; Haiyan Fu; Douglas M McCarty
Journal:  Mol Ther       Date:  2012-09-18       Impact factor: 11.454

5.  Gene delivery to mitochondria by targeting modified adenoassociated virus suppresses Leber's hereditary optic neuropathy in a mouse model.

Authors:  Hong Yu; Rajeshwari D Koilkonda; Tsung-Han Chou; Vittorio Porciatti; Sacide S Ozdemir; Vince Chiodo; Sanford L Boye; Shannon E Boye; William W Hauswirth; Alfred S Lewin; John Guy
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-20       Impact factor: 11.205

6.  The Sequence Alignment/Map format and SAMtools.

Authors:  Heng Li; Bob Handsaker; Alec Wysoker; Tim Fennell; Jue Ruan; Nils Homer; Gabor Marth; Goncalo Abecasis; Richard Durbin
Journal:  Bioinformatics       Date:  2009-06-08       Impact factor: 6.937

7.  AAV serotype 2 vectors preferentially integrate into active genes in mice.

Authors:  Hiroyuki Nakai; Eugenio Montini; Sally Fuess; Theresa A Storm; Markus Grompe; Mark A Kay
Journal:  Nat Genet       Date:  2003-07       Impact factor: 38.330

8.  DNA palindromes with a modest arm length of greater, similar 20 base pairs are a significant target for recombinant adeno-associated virus vector integration in the liver, muscles, and heart in mice.

Authors:  Katsuya Inagaki; Susanna M Lewis; Xiaolin Wu; Congrong Ma; David J Munroe; Sally Fuess; Theresa A Storm; Mark A Kay; Hiroyuki Nakai
Journal:  J Virol       Date:  2007-08-08       Impact factor: 5.103

9.  New genes involved in cancer identified by retroviral tagging.

Authors:  Takeshi Suzuki; Haifa Shen; Keiko Akagi; Herbert C Morse; James D Malley; Daniel Q Naiman; Nancy A Jenkins; Neal G Copeland
Journal:  Nat Genet       Date:  2002-08-19       Impact factor: 38.330

10.  Real-time definition of non-randomness in the distribution of genomic events.

Authors:  Ulrich Abel; Annette Deichmann; Cynthia Bartholomae; Kerstin Schwarzwaelder; Hanno Glimm; Steven Howe; Adrian Thrasher; Alexandrine Garrigue; Salima Hacein-Bey-Abina; Marina Cavazzana-Calvo; Alain Fischer; Dirk Jaeger; Christof von Kalle; Manfred Schmidt
Journal:  PLoS One       Date:  2007-06-27       Impact factor: 3.240

View more
  70 in total

1.  Adeno-associated Vector Toxicity-To Be or Not to Be?

Authors:  Hildegard Büning; Manfred Schmidt
Journal:  Mol Ther       Date:  2015-11       Impact factor: 11.454

Review 2.  The potential of adeno-associated viral vectors for gene delivery to muscle tissue.

Authors:  Dan Wang; Li Zhong; M Abu Nahid; Guangping Gao
Journal:  Expert Opin Drug Deliv       Date:  2014-01-03       Impact factor: 6.648

3.  Improving lipoprotein profiles by liver-directed gene transfer of low density lipoprotein receptor gene in hypercholesterolaemia mice.

Authors:  Hailong Ou; Qinghai Zhang; Jia Zeng
Journal:  J Genet       Date:  2016-06       Impact factor: 1.166

Review 4.  Gene therapy for hemophilia: what does the future hold?

Authors:  Bhavya S Doshi; Valder R Arruda
Journal:  Ther Adv Hematol       Date:  2018-08-27

Review 5.  Intratympanic Gene Delivery of Antimicrobial Molecules in Otitis Media.

Authors:  Sung K Moon; David J Lim
Journal:  Curr Allergy Asthma Rep       Date:  2015-04       Impact factor: 4.806

6.  Short DNA Hairpins Compromise Recombinant Adeno-Associated Virus Genome Homogeneity.

Authors:  Jun Xie; Qin Mao; Phillip W L Tai; Ran He; Jianzhong Ai; Qin Su; Ye Zhu; Hong Ma; Jia Li; Shoufang Gong; Dan Wang; Zhen Gao; Mengxin Li; Li Zhong; Heather Zhou; Guangping Gao
Journal:  Mol Ther       Date:  2017-04-24       Impact factor: 11.454

Review 7.  Adeno-associated virus-mediated microRNA delivery and therapeutics.

Authors:  Jun Xie; Daniel Robert Burt; Guangping Gao
Journal:  Semin Liver Dis       Date:  2015-01-29       Impact factor: 6.115

Review 8.  State-of-the-art human gene therapy: part I. Gene delivery technologies.

Authors:  Dan Wang; Guangping Gao
Journal:  Discov Med       Date:  2014 Jul-Aug       Impact factor: 2.970

9.  Homologous Recombination-Based Genome Editing by Clade F AAVs Is Inefficient in the Absence of a Targeted DNA Break.

Authors:  Geoffrey L Rogers; Hsu-Yu Chen; Heidy Morales; Paula M Cannon
Journal:  Mol Ther       Date:  2019-09-09       Impact factor: 11.454

Review 10.  Adeno-associated viral vectors for the treatment of hemophilia.

Authors:  Katherine A High; Xavier M Anguela
Journal:  Hum Mol Genet       Date:  2015-11-27       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.